» Articles » PMID: 27601922

Risk Prediction and Clinical Model Building for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2016 Sep 8
PMID 27601922
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The surgical management of papillary thyroid microcarcinoma (PTMC), especially regarding the necessity of central/lateral lymph node dissection, remains controversial. This study investigated the clinicopathologic factors predictive of lymph node metastasis (LNM) in patients diagnosed with PTMC. Multivariate logistic regression analysis was used for PTMC patients identified from the Surveillance, Epidemiology, and End Results database who were treated by surgery between 2002 and 2012, to determine the association of clinicopathologic factors with LNM. According to the results, a total of 31,017 patients met the inclusion criteria of the study. Final histology confirmed 2,135 (6.9%) cases of N1a disease and 1,684 cases (5.4%) of N1b disease. Our multivariate logistic regression analysis identified variables associated with both central LNM and lateral lymph node metastasis (LLNM), including a younger age (<45 years), male sex, non-Hispanic white and other race, classical papillary histology, larger tumor size, multifocality, and extrathyroidal extension; distant metastasis was also significantly associated with LLNM. The significant predictors identified from multivariable logistic regression were integrated into a statistical model that showed that extrathyroidal extension had maximum weight in the predictive role for LNM. LLNM was validated to be a significant risk factor for cancer-specific death in Cox regression analyses, whereas central LNM failed to predict a worse cancer-specific survival according to our data. Therefore, we suggested that central lymph node dissection could be performed in certain patients with risk factors. Given the prevalence of LLNM in PTMC, a thorough inspection of the lateral compartment is recommended in PTMC patients with risk factors for precise staging; from the viewpoint of a radical treatment for tumors, prophylactic lateral lymph node dissection that aims to remove the occult lateral lymph nodes may be an option for PTMC with risk factors. Multicenter studies with long-term follow-up are recommended to better understand the risk factors and surgical management for cervical nodes in PTMC.

Citing Articles

Proteomic Analysis of Tissue Proteins Related to Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.

Zhang Q, Cao Z, Wang Y, Wu H, Zhang Z, Liu Z J Proteome Res. 2024; 24(1):256-267.

PMID: 39600146 PMC: 11705366. DOI: 10.1021/acs.jproteome.4c00737.


Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis.

Cao Z, Wang Y, Wu J, Tang X, Qian Z, Zhang Z Cancer Gene Ther. 2024; 32(1):38-50.

PMID: 39558134 PMC: 11772248. DOI: 10.1038/s41417-024-00854-9.


Risk stratification for central lymph node metastasis in mono-focal papillary thyroid carcinoma patients with encapsulated tumor as confirmed by preoperative ultrasound: a multi-center analysis.

Ji Y, Heng Y, Wang Z, Cai W, Wu C, Yang Z Endocrine. 2024; 86(3):1045-1054.

PMID: 39052200 DOI: 10.1007/s12020-024-03861-w.


Evaluation of Hematoma Formation after Thyroidectomy Surgery and Its Related Factors.

Sarmast Shoushtari M, Sherafatmand S, Rostami A, Mohammadi A, Shayesteh B, Farhadi F World J Plast Surg. 2024; 13(1):37-42.

PMID: 38742026 PMC: 11088728. DOI: 10.61186/wjps.13.1.37.


Clinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.

Lim J, Lee H, Heo J, Song Y Endocrinol Metab (Seoul). 2024; 39(2):324-333.

PMID: 38572535 PMC: 11066436. DOI: 10.3803/EnM.2023.1885.


References
1.
Moon H, Kim E, Yoon J, Kwak J . Clinical implication of elastography as a prognostic factor of papillary thyroid microcarcinoma. Ann Surg Oncol. 2012; 19(7):2279-87. DOI: 10.1245/s10434-011-2212-3. View

2.
Zhang L, Wei W, Ji Q, Zhu Y, Wang Z, Wang Y . Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab. 2012; 97(4):1250-7. DOI: 10.1210/jc.2011-1546. View

3.
Lee J, Park J, Lee C, Chung W, Park C . Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching. Thyroid. 2013; 23(11):1408-15. DOI: 10.1089/thy.2012.0463. View

4.
Lee C, Kim S, Ko K, Chung K, Lee J . Predictive factors for extrathyroidal extension of papillary thyroid carcinoma based on preoperative sonography. J Ultrasound Med. 2014; 33(2):231-8. DOI: 10.7863/ultra.33.2.231. View

5.
Harrell Jr F, Lee K, Mark D . Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15(4):361-87. DOI: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4. View